The New Delhi-based Ranbaxy Laboratories has acquired Mundogen, the generic business of GlaxoSmithKline in Spain, for an undisclosed sum.This would be the second acquisition by Ranbaxy in the......
N Prasad's vision is to transform Matrix Laboratories into a highly respected global corporate entity based out of India by 2010 and also enhance stakeholders' wealth. And, he seems to be well on......
In the largest overseas acquisition by an Indian pharmaceutical company, Hyderabad-based Matrix Laboratories Ltd is acquiring a controlling stake in Docpharma NV, one of the leading generic drug......
Ranbaxy Laboratories will set up a majority-owned joint venture in Mexico to tap the growing demand for generic drugs there.The joint venture with a Mexican firm will cater to the marketing and......
Pharmaceutical major Ranbaxy Laboratories on Friday said it will set up a wholly-owned subsidiary in Spain as part of its strategy to expand presence in Europe.The move comes close on the heels of......